The neoplastic tissue had a positive expression of PRL-3 in 42.2 % (30/71) of gastric cancer cases, whereas abnormal expression of E-cadherin was observed in 38 % (27/71) of cases (Fig. 1). The gene discussed is CDH1; the disease is gastric cancer.